Status:
COMPLETED
Cohort of HIV Associated Lymphomas
Lead Sponsor:
ANRS, Emerging Infectious Diseases
Collaborating Sponsors:
Dr Yassine Taoufik Dr Houria Chavez Hôpital Bicêtre CIB Paris Sud France
Dr Guislaine Garcelain Hôpital Pitié Slapétrière Paris France
Conditions:
HIV Infection
Eligibility:
All Genders
18-65 years
Brief Summary
The incidence of lymphomas is increased among HIV infected patients. In 70 % of cases, those are Non Hodgkin's lymphomas (NHL) and Hodgkin lymphomas (HL) in 30% of cases. In France, their incidence is...
Eligibility Criteria
Inclusion
- Male and female patients over 18 years of age
- patients with HIV-1 or 2 infection
- with Non Hodgkin's lymphomas (NHL) or Hodgkin lymphomas (HL) in the diagnosis or in relapse
- sign an informed consent
Exclusion
- patients who suffered from acute leukemia
- patients treated for lymphoïd blood disease
- Patients whose lymphomas treatment was stopped for less than 3 months
- unaffiliated to the social healthy security french system
Key Trial Info
Start Date :
June 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2017
Estimated Enrollment :
205 Patients enrolled
Trial Details
Trial ID
NCT01164436
Start Date
June 1 2008
End Date
June 1 2017
Last Update
November 6 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
BESSON
Paris, France